Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,178 total articles

Analyst Upgrade Sparks Pre-Market Pop in Sweetgreen Shares

Analyst Upgrade Sparks Pre-Market Pop in Sweetgreen Shares

Shares of Sweetgreen climbed in pre-market trading after KeyBanc upgraded the fast-casual chain from Sector Weight to Overweight and set a $9.00 price target. The bank substantially raised its same-store sales and profitability forecasts for 2026 and 2027, citing signs that traffic and sales trends have stabilized, a view that traders interpreted a…

Solaris Energy Infrastructure Raises EBITDA Targets, Shares Tick Higher

Solaris Energy Infrastructure Raises EBITDA Targets, Shares Tick Higher

Solaris Energy Infrastructure (NYSE: SEI) reported raised Adjusted EBITDA guidance for the third and fourth quarters of 2026 and provided an initial projection for the first quarter of 2027. The stock climbed about 6% on the news as the company cited stronger contributions from core power services and better-than-expected results from recently acqu…

Intel Shares Jump as Company Prepares Another CPU Price Increase and Highlights Manufacturing Milestone

Intel Shares Jump as Company Prepares Another CPU Price Increase and Highlights Manufacturing Milestone

Intel shares rose sharply in pre-market trade after supply-chain sources reported the company will raise PC CPU prices by about 10% in early October, part of a broader pricing strategy to improve gross margins. The move coincided with an analyst upgrade from Northland and a manufacturing milestone for Intel Foundry using High NA EUV lithography, cr…

Inhibrx Shares Rise After Strong Phase 2 Data for INBRX-106 Plus Pembrolizumab in Head and Neck Cancer

Inhibrx Shares Rise After Strong Phase 2 Data for INBRX-106 Plus Pembrolizumab in Head and Neck Cancer

Inhibrx Biosciences saw its stock climb after the company disclosed positive Phase 2 results from the HexAgon study evaluating INBRX-106 in combination with pembrolizumab for first-line, PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The combo produced higher confirmed objective response and six-month pro…

Herbalife Announces $250 Million Share Repurchase; Stock Climbs 5%

Herbalife Announces $250 Million Share Repurchase; Stock Climbs 5%

Herbalife Nutrition Ltd. said its board approved a $250 million share repurchase program that will run for three years, enabling purchases via open market transactions, negotiated deals and accelerated share repurchases. Shares rose about 5% on the announcement. Management cited confidence in the company's financial profile, free cash flow generati…

D-Wave Gains After Securing Up to $100M in CHIPS Act Support

D-Wave Gains After Securing Up to $100M in CHIPS Act Support

D-Wave Quantum shares rose 4.5% on Tuesday after the company finalized a definitive agreement with the U.S. Department of Commerce to receive up to $100 million in CHIPS and Science Act funding. The financing is earmarked for research and development across D-Wave’s superconducting annealing and gate-model platforms and is tied to a minority, non-c…